Expand NBIX Menu
NBIX MENU

NBIX Stock Posts


Unusual Option Volume

NBIX Neurocrine Biosciences122.67-14.77 (-10.8%)

Neurocrine Biosciences trades 3,553 contracts. News: Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026
View Details...
NBIX #NeurocrineBiosciences stock declines -3.6% in after hours trading. See the latest news.

After Hours Decliner

NBIX Neurocrine Biosciences137.44-0.21-0.2%

After Hours:132.50-4.94 (-3.6%)

Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026

PRNewswireWed, 11-Feb 4:01 PM
NBIX #NeurocrineBiosciences stock declines -1.8% in after hours trading. See the latest news.

After Hours Decliner

NBIX Neurocrine Biosciences137.44-0.21-0.2%

After Hours:134.96-2.48 (-1.8%)

Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026

PRNewswireWed, 11-Feb 4:01 PM
Upcoming Earnings

NBIX Neurocrine Biosciences135.11-2.54 (-1.9%)

Neurocrine Biosciences will report earnings after the market closes. View Calendar The market is expecting a ±8.2% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±9.9%. View Expected Move (Conf Call: Feb 11 4:30 PM)
Unusual Option Volume

NBIX Neurocrine Biosciences131.76-3.57 (-2.6%)

Neurocrine Biosciences trades 2,653 contracts. The company has the following event: American College of Neuropsychopharmacology 64th Annual Meeting on Jan 15, 2026. News: Neurocrine Biosciences Presents Head-to-Head INGREZZA (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
View Details...
Unusual Option Volume

NBIX Neurocrine Biosciences136.53-10.85 (-7.4%)

Neurocrine Biosciences trades 2,577 contracts. News: Neurocrine Biosciences Reports Third Quarter 2025 Financial Results
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes